JP2012529272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012529272A5 JP2012529272A5 JP2012514307A JP2012514307A JP2012529272A5 JP 2012529272 A5 JP2012529272 A5 JP 2012529272A5 JP 2012514307 A JP2012514307 A JP 2012514307A JP 2012514307 A JP2012514307 A JP 2012514307A JP 2012529272 A5 JP2012529272 A5 JP 2012529272A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- angiopep
- disease
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18624609P | 2009-06-11 | 2009-06-11 | |
| US61/186,246 | 2009-06-11 | ||
| PCT/CA2010/000889 WO2010142035A1 (en) | 2009-06-11 | 2010-06-11 | Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012529272A JP2012529272A (ja) | 2012-11-22 |
| JP2012529272A5 true JP2012529272A5 (https=) | 2013-07-25 |
Family
ID=43308346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012514307A Pending JP2012529272A (ja) | 2009-06-11 | 2010-06-11 | Ｇｄｎｆおよびｂｄｎｆを中枢神経系へ送達するための融合タンパク質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120196803A1 (https=) |
| EP (1) | EP2440581A4 (https=) |
| JP (1) | JP2012529272A (https=) |
| CN (2) | CN103819564A (https=) |
| AU (1) | AU2010258052A1 (https=) |
| BR (1) | BRPI1012971A2 (https=) |
| CA (1) | CA2764777A1 (https=) |
| MX (1) | MX2011013258A (https=) |
| WO (1) | WO2010142035A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004060403A2 (en) | 2003-01-06 | 2004-07-22 | Angiochem Inc. | Aprotinin and anglos as carriers across the blood-brain barrier |
| ES2744225T3 (es) | 2005-07-15 | 2020-02-24 | Angiochem Inc | Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos |
| JP2010506860A (ja) | 2006-10-19 | 2010-03-04 | アンジオケム，インコーポレーテッド | Ｐ−糖タンパク質機能を刺激するための化合物およびその使用 |
| US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| CA2740316A1 (en) | 2008-10-15 | 2010-04-22 | Angiochem Inc. | Conjugates of glp-1 agonists and uses thereof |
| CA2745524C (en) | 2008-12-05 | 2020-06-09 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
| US8853353B2 (en) | 2008-12-17 | 2014-10-07 | Angiochem, Inc. | Membrane type-1 matrix metalloprotein inhibitors and uses thereof |
| MX2011011023A (es) | 2009-04-20 | 2012-01-20 | Angiochem Inc | Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2. |
| RU2012103240A (ru) | 2009-07-02 | 2013-08-10 | Ангиокем Инк. | Мультимерные пептидные конъюгаты и их применение |
| WO2011153642A1 (en) * | 2010-06-10 | 2011-12-15 | Angiochem Inc. | Leptin and leptin analog conjugates and fusion proteins and uses thereof |
| JP2013530993A (ja) * | 2010-07-02 | 2013-08-01 | アンジオケム インコーポレーテッド | 治療用コンジュゲートのための短く且つｄ−アミノ酸を含有するポリペプチドおよびその使用 |
| JP2015526434A (ja) | 2012-08-14 | 2015-09-10 | アンジオケム インコーポレーテッド | ペプチド−デンドリマーコンジュゲート及びその使用 |
| JP6234331B2 (ja) * | 2014-06-13 | 2017-11-22 | 森永乳業株式会社 | 統合失調症治療剤 |
| EP3307326B9 (en) | 2015-06-15 | 2021-02-24 | Angiochem Inc. | Methods for the treatment of leptomeningeal carcinomatosis |
| EP3454886A1 (en) | 2016-05-13 | 2019-03-20 | Instituto de Medicina Molecular | Methods of treating diseases associated with ilc3 cells |
| WO2018089702A1 (en) * | 2016-11-10 | 2018-05-17 | Keros Therapeutics, Inc. | Gdnf fusion polypeptides and methods of use thereof |
| CN107141354A (zh) * | 2017-05-05 | 2017-09-08 | 李斯文 | 一种融合蛋白及光敏剂复合物及其制备方法和应用 |
| CN114729324A (zh) * | 2019-07-24 | 2022-07-08 | 斯比根公司 | 永生化干细胞株的制备方法及其用途 |
| EP4347645A1 (en) | 2021-06-03 | 2024-04-10 | Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud Foundation | Neuro-mesenchyme units control ilc2 and obesity via a brain-adipose circuit |
| CN116270429B (zh) * | 2023-02-17 | 2025-06-10 | 山东省药学科学院 | 一种鼻黏膜给药的抗抑郁制剂及其制备方法和应用 |
| AU2024354107A1 (en) * | 2023-09-28 | 2026-04-16 | Bebetter Med Inc. | Sirna inhibiting expression of amyloid precursor protein (app) gene, drug, and use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2408605C2 (ru) * | 2005-02-18 | 2011-01-10 | Анджиокем Инк. | Полипептид, способный преодолевать гематоэнцефалический барьер, и его конъюгат |
| US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
| US8053569B2 (en) * | 2005-10-07 | 2011-11-08 | Armagen Technologies, Inc. | Nucleic acids encoding and methods of producing fusion proteins |
| AU2008255556B2 (en) * | 2007-05-29 | 2014-08-07 | Angiochem, Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| US8802631B2 (en) * | 2007-09-17 | 2014-08-12 | Ludwig Institute For Cancer Research Ltd. | Peptides and methods for the treatment of gliomas and other cancers |
| WO2009070597A2 (en) * | 2007-11-26 | 2009-06-04 | Armagen Technologies, Inc. | Fusion proteins for delivery of gdnf to the cns |
-
2010
- 2010-06-11 CN CN201410030902.XA patent/CN103819564A/zh active Pending
- 2010-06-11 JP JP2012514307A patent/JP2012529272A/ja active Pending
- 2010-06-11 MX MX2011013258A patent/MX2011013258A/es not_active Application Discontinuation
- 2010-06-11 WO PCT/CA2010/000889 patent/WO2010142035A1/en not_active Ceased
- 2010-06-11 CA CA2764777A patent/CA2764777A1/en not_active Abandoned
- 2010-06-11 AU AU2010258052A patent/AU2010258052A1/en not_active Abandoned
- 2010-06-11 BR BRPI1012971A patent/BRPI1012971A2/pt not_active IP Right Cessation
- 2010-06-11 EP EP10785633A patent/EP2440581A4/en not_active Withdrawn
- 2010-06-11 CN CN2010800317596A patent/CN102459348A/zh active Pending
- 2010-06-11 US US13/377,480 patent/US20120196803A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012529272A5 (https=) | ||
| JP2010534486A5 (https=) | ||
| ES2397660T3 (es) | Método para la producción de conjugados de factor I de crecimiento similar a la insulina y polietilenglicol | |
| ES2393373T3 (es) | Método para la producción de factor-I de crecimiento similar a la insulina | |
| JP2009515529A5 (https=) | ||
| JP2023181445A5 (https=) | ||
| TW200833840A (en) | Toxin peptide therapeutic agents | |
| JP2013523718A5 (https=) | ||
| JP2005507637A5 (https=) | ||
| CN103998458A (zh) | 具有中央疏水域的细胞穿透肽 | |
| JP2014525901A5 (https=) | ||
| JP2008508859A5 (https=) | ||
| NO330538B1 (no) | Anvendelse av hydrofob ladningsinduksjonskromatografi for fremstilling av renset IL-18-bindende protein samt fremgangsmate for fremstilling av renset IL -18-bindende protein | |
| JP2013526864A5 (https=) | ||
| JP2010524958A5 (https=) | ||
| JPH10182700A (ja) | 高圧液体クロマトグラフィーによるインシュリンの単離方法 | |
| JP2016525545A5 (https=) | ||
| JP2014510101A5 (https=) | ||
| JP2023528204A5 (https=) | ||
| JP2007535910A5 (https=) | ||
| JP2024012470A5 (https=) | ||
| JP2009507503A5 (https=) | ||
| JP2025120320A (ja) | Ｖｉｐｒ２アンタゴニストペプチド | |
| RU2007146455A (ru) | Варианты эритропоэтина | |
| JP2008539745A5 (https=) |